Connect with us

Media OutReach

“No Limits” 2026: A Celebration of Inclusion and Creativity All of Us, All Ways

Published

on

11 Extraordinary Programmes Featuring Differently-Abled Local and International Artists Tickets Now Available at URBTIX

HONG KONG SAR – Media OutReach Newswire – 11 December 2025 – The eighth edition of “No Limits”, co-presented by the Hong Kong Arts Festival (HKAF) and The Hong Kong Jockey Club Charities Trust, will open on 27 February 2026 (Friday), under the theme “All of Us, All Ways”. This year’s programme invites audiences to reimagine the value of diversity through inclusion, celebrating the extraordinary talent and creativity of local and international artists of varying abilities.

“No Limits” 2026 presents 11 groundbreaking works across music, theatre, dance and film, with a total of 29 performances and events. The season also features over 20 Jockey Club “No Limits” Education and Community Programmes, including school tours, workshops, public showcases and an international symposium. These events aim to foster greater understanding, creativity and connection across communities.

This year marks an important milestone for “No Limits” as it collaborates for the first time with two of Hong Kong’s flagship performing arts companies—the Hong Kong Dance Company and the Hong Kong Chinese Orchestra—to present multidisciplinary inclusive programmes. These trailblazing partnerships highlight the growing integration of inclusivity into Hong Kong’s mainstream cultural landscape.

Celebrating its eighth edition, the theme of this year’s “No Limits” – “All of Us, All Ways” – reflects its commitment to promoting diversity and connecting people through the arts. By embracing differences and fostering inclusive collaborations, “No Limits” seeks to inspire new perspectives and unlock the imaginative possibilities that diversity brings. Building on the success of the 2025 “No Limits”‘ International Symposium, the programme continues to promote the growth of an Asian network of inclusive arts partners. In this way, “No Limits” reaffirms its vision of becoming a transformative force both locally and regionally.

Tickets to all performances are now available at URBTIX. A limited early bird offer of a 20% discount on all standard price tickets will be available until 5 January 2026. Half-price tickets are available for full-time students, people with disabilities and one companion, and Comprehensive Social Security Assistance (CSSA) recipients. (Link: www.urbtix.hk/series/124?bannerCode=NL2026)

Community programmes, including public showcases and screenings, are free of charge and open to everyone. Selected online programmes can also be accessed for free on the official website, https://www.nolimits.hk.

In collaboration with the Arts with the Disabled Association Hong Kong, “No Limits” will once again provide a range of accessibility services, including audio description, Hong Kong sign language interpretation, accessible captions, braille and audio booklets, and relaxed performances. Additional wheelchair seats may be available in some venues. Guide dogs are welcome.

To carry the spirit of inclusion beyond the stage, “No Limits” is launching a series of inclusive-themed plush toys. Purchasers of tickets worth HK$500 or more in a single transaction will receive a souvenir plush toy, while stocks last.

In-venue Programme

Opening Programme: The Nature of Why

The internationally acclaimed Paraorchestra, the world’s first professional inclusive orchestra, presents an immersive symphonic dance-theatre experience inspired by Nobel Prize-winning physicist Richard Feynman. Featuring live orchestral music, contemporary dance and audience interaction, this groundbreaking performance challenges perceptions of inclusion and art.

Dates: 27 February – 1 March 2026, Auditorium, Kwai Tsing Theatre

Wayfaring Beyond

A unique outdoor performance co-produced by the Hong Kong Dance Company and the China Hong Kong Para Dance Sport Association. Drawing on Daoist philosophy, this powerful collaboration blends traditional Chinese dance and wheelchair dance sport, exploring the beauty of diverse physicality and the freedom that transcends the body.

Dates: 28 February – 1 March 2026, Parade Ground, Tai Kwun

Light and Shadow on Strings

The Hong Kong Chinese Orchestra, in collaboration with visually impaired erhu prodigy Yang Enhua, presents a mesmerising concert of traditional and contemporary Chinese string music. The programme also includes a newly commissioned work inspired by the experiences of visually impaired individuals.

Date: 28 March 2026, Auditorium, Tsuen Wan Town Hall

Two Blind Women in the Snowy Tokugawa Nights – Sleeping Fires

Commissioned by “No Limits”, director Kuro Tanino creates a poignant and visually stunning theatrical work inspired by the lives of blind massage therapists in ancient times. This world premiere reflects on themes of trust, independence and belonging.

Dates: 27–29 March 2026, Studio Theatre, Hong Kong Cultural Centre

Zer-Brech-Lich

Swiss choreographer Alessandro Schiattarella presents a witty and heartfelt musical theatre performance led by three disabled performers. Through original music and dance, the production transforms vulnerability into a celebration of strength and diversity.

Dates: 13–15 March 2026, Black Box Theatre, Kwai Tsing Theatre

Precarious Moves

Vienna-based artist Michael Turinsky performs a thought-provoking solo exploring the choreography of resistance and the relationship between body, time and space. This work challenges societal expectations surrounding disabled bodies.

Dates: 17–18 March 2026, The Box, Freespace, WestK

Harmonia

This award-winning dance work by Theatre Bremen and choreographer Adrienn Hód dismantles conventional notions of the body in dance. Featuring a diverse cast of performers with and without disabilities, the piece highlights the possibilities of inclusive choreography.

Dates: 21–22 March 2026, The Box, Freespace, WestK

Free Screenings and Online Programmes

“No Limits” 2026 offers an exciting selection of films and documentaries that highlight themes of inclusion, resilience and the human experience. These screenings are free of charge, with in-venue viewings at Tai Kwun Laundry Steps and online accessibility through the “No Limits” website*.

A Space in Time (Riccardo Servini and Nick Taussig)

A heartfelt documentary capturing the journey of a family raising two sons with Duchenne muscular dystrophy. Through interviews and candid home videos, this film explores their resilience and the role of supportive communities.

Dates: 17 January (Sat) & 18 January (Sun), 3:20 PM
Language: English with Chinese and English subtitles, Cantonese dubbing, and audio description in Cantonese.

Away from Her (Sarah Polley)

A poignant feature film about love, memory and loss, as a married couple of over 40 years faces the challenges of early-onset Alzheimer’s disease. Based on the short story The Bear Came Over the Mountain by Alice Munro.

Dates: 17 January (Sat) & 18 January (Sun), 4:50 PM
Language: English with Chinese and English subtitles, Cantonese dubbing, and audio description in Cantonese.

Lapse (Caroline Cavalcanti)

A Brazilian short film about friendship and understanding, as two teenagers—one a deaf skateboarder, the other a rap enthusiast—form a connection through sign language and shared struggles.

Dates: 28 February (Sat) & 1 March (Sun), 5:45 PM; 7 March (Sat) & 8 March (Sun), 3:10 PM
Language: Portuguese with Chinese and English subtitles, Cantonese dubbing, and audio description in Cantonese.

Fujiyama Cottonton (Taku Aoyagi)

A reflective Japanese documentary set at Mirai Farm, a facility for differently-abled individuals, exploring their daily lives, creativity and the beauty of community. Inspired by the French film On the Adamant.

Dates: 7 March (Sat) & 8 March (Sun), 3:35 PM
Language: Japanese with Chinese and English subtitles, Cantonese dubbing, and audio description in Cantonese.

*From 30 March to 25 May 2026, all films will be available for free online viewing. Each film includes Chinese and English accessible subtitles, Cantonese and English dubbing, and audio description services in both languages.

Audiences can visit https://www.nolimits.hk to stream these films free of charge during the scheduled dates.

Jockey Club “No Limits” Education and Community Programme

The Jockey Club “No Limits” Education and Community Programme continues to promote inclusion and creativity through a range of impactful initiatives, including community showcases, a school touring programme, a creative training programme, an international symposium and an innovative research scheme.

Community Showcases and Live Screenings

Taking place on 17–18 January and 7–8 March 2026 at the Laundry Steps, Tai Kwun, these showcases feature performances co-created by participants of the Pilot Creative Training Programme and community organisations. The events also include live performances, post-show sharing sessions and film screenings. Accessibility features include audio description, sign language interpretation and subtitles in Chinese and English. Admission is free, with no registration required.

Pilot Creative Training Programme

Running from September to October 2025, this programme, in collaboration with Candoco Dance Company (UK), offers two pathways:

  • Fundamental Course: For teaching artists with 0–2 years’ experience, focusing on inclusive teaching methods.
  • Advanced Course: For experienced teaching artists, exploring reflective and innovative practices.

Participants will undertake three-month placements at community centres, co-creating workshops with individuals of all abilities. The results will be performed during the Community Showcases.

School Touring Programme: “The Ways We Move”

In March 2026, this a cappella concert will tour schools, featuring choirs of mixed abilities performing original and popular songs inspired by real-life stories. The performance explores how we express ourselves through our bodies and emotions, inviting students to participate in group singing and movement activities. Schools can enquire at [email protected].

International Symposium: “The Way Forward: A Humanistic–Tech Framework for Inclusive Innovation”

To be held on 8 March 2026 at JC Cube, Tai Kwun, this symposium brings together experts from arts, technology, urban planning, healthcare and community advocacy to discuss how creativity and technology can drive inclusion. Topics include democratising access to the arts, sensory design in urban planning, and co-creation with disabled individuals. The event is free of charge with Cantonese and English interpretation provided.

Local Creative Research and Development Scheme

This nine-month initiative pairs local artists with individuals of different abilities to co-create new works exploring inclusive practices. Highlights include:

  • Jezrael Lucero and Daniel Chu: Exploring Lucero’s journey as a blind Filipino jazz musician.
  • Miu Law and Sham Chung-tat: Redefining mapmaking through sound and tactile experiences.
  • Amy Chan and Chu Po: Investigating creativity and societal norms through ceramics and light.
  • Tsz Wai-pun and Nathan Fong: Combining robotics and puppetry to innovate storytelling.

The results will be presented as part of “No Limits” 2026, showcasing the potential of inclusive arts to audiences.

Arts Accessibility Services

“No Limits” continues its collaboration with the Arts with the Disabled Association Hong Kong to offer a range of accessibility services, including audio description, Hong Kong sign language interpretation, accessible captions, braille and audio booklets, and relaxed performances; additional wheelchair seats may be available in some venues. Guide dogs are welcome.

For more event details, please visit the “No Limits” website: www.nolimits.hk
Click here for programme details: www.nolimits.hk/programme
Urbtix: https://www.urbtix.hk/series/124?bannerCode=NL2026
Click here to download programme images.

Appendix

Programme

Date Programme Performer/ Director Venue
Highlights
27 Feb – 1 Mar 2026 The Nature of Why Paraorchestra Auditorium,

Kwai Tsing Theatre

28 Feb – 1 Mar 2026 Wayfaring Beyond Hong Kong Dance Company & China Hong Kong Para Dance Sport Association Parade Ground,

Tai Kwun

13-15 Mar 2026 Zer-Brech-Lich Alessandro Schiattarella and Ensemble Black Box Theatre,

Kwai Tsing Theatre

17-18 Mar 2026 Precarious Moves Michael Turinsky The Box,

Freespace, WestK

21-22 Mar 2026 Harmonia Unusual Symptoms / Theatre Bremen / Adrienn Hód The Box,

Freespace, WestK

27-29 Mar 2026 Two Blind Women in the Snowy Tokugawa Nights – Sleeping Fires Kuro Tanino Studio Theatre, Hong Kong Cultural Centre
28 Mar 2026 Light and Shadow on Strings Hong Kong Chinese Orchestra (Chamber Ensemble)

Yang Enhua (Solo and Ensemble)

Auditorium,

Tsuen Wan Town Hall

“No Limits” International Symposium
8 Mar 2026 The Way Forward: A Humanistic–Tech Framework for Inclusive Innovation JC Cube, Tai Kwun

Free Screenings and Online Programmes

In-venue Free Screening @Laundry Steps, Tai Kwun Free screening available on “No Limits” website Programme Director
17-18 Jan 2026 30 Mar – 25 May 2026 A Space in Time Riccardo Servini & Nick Taussig
17-18 Jan 2026 30 Mar – 25 May 2026 Away From Her Sarah Polley
28 Feb – 1 Mar,

7 – 8 Mar 2026

30 Mar – 25 May 2026 Lapse Caroline Cavalcanti
7 – 8 Mar 2026 30 Mar – 25 May 2026 Fujiyama Cottonton Taku Aoyagi

Hashtag: #NoLimits

The issuer is solely responsible for the content of this announcement.

About the Hong Kong Arts Festival

Launched in 1973, the Hong Kong Arts Festival is a major international arts festival committed to enriching the cultural life of the city. In February and March every year, the Festival presents leading local and international artists from all genres of the performing arts, giving equal importance to great traditions and contemporary creations. The Festival also commissions and produces work in theatre, music, chamber opera and contemporary dance by Hong Kong’s own creative talents and emerging artists, many of which have subsequently had successful runs in Hong Kong and overseas. Every year, the Festival also presents more than 250 “PLUS” and educational activities that offer diverse arts experiences to the community as well as tertiary, secondary and primary school students. In addition, through the “No Limits” project co-presented with The Hong Kong Jockey Club Charities Trust, the Festival strives to create an inclusive space for people of different abilities to share the joy of the arts together.

For more information about the Hong Kong Arts Festival, please visit .

About “No Limits”

Launched in 2019 and co-presented by the Hong Kong Arts Festival and The Hong Kong Jockey Club Charities Trust, “No Limits” offers barrier-free performances and events, and explores and promotes inclusiveness and understanding through the arts.

In 2026, the eighth edition of “No Limits” showcases a series of fascinating programmes of music, dance, theatre and film by international and Hong Kong artists of different abilities.

“No Limits” 2026 presents accessible in-venue performances, free film screenings and a symposium, as well as education and community programmes for young people, highlighting creativity and talent in a variety of forms.

For more information about “No Limits”, please visit

Advertisement

Media OutReach

MIMO: The AI-Native Storage Species Enables Desktop Scale AI Clusters With NVIDIA DGX Spark

Published

on

  • Engineered for the AI era, MIMO delivers breakthrough metrics: 400 GB/s bandwidth, 54 million IOPS, and 40–90 μs latency—all within a form factor comparable to a large suitcase.
  • MIMO serves as both a high-performance data hub for large-scale GPU clusters and a flexible edge deployment platform, extending seamlessly to desktop environments where it orchestrates workflows with various DGX Spark units based on NVIDIA’s GB10 Grace Blackwell superchip.
  • This architecture enables independent AI clusters supporting up to 16 computing nodes within constrained environments, managing the complete workflow from large-scale pre-training and fine-tuning to production inference—effectively democratizing enterprise-grade AI capabilities for labs, edge sites, and distributed teams.

SINGAPORE –

Professor Zhang Sheng from Tsinghua University Shenzhen International Graduate School expressed a more pragmatic view: “With this solution, we finally no longer have to rely on the university’s data center. Our current annual budget alone is enough to deploy an AI cluster within our lab that better fits our needs—this will significantly boost our research efficiency both technically and operationally. It’s truly fantastic news.”

Asia Debut Marks Industry Inflection Point

Earlier at the 8th China International Import Expo (CIIE), the solution’s core—the world’s first AI-native storage system MIMO—made its strategic Asian debut. Engineered for the AI era, MIMO delivers breakthrough metrics: 400 GB/s bandwidth, 54 million IOPS, and 40–90 μs latency—all within a form factor comparable to a large suitcase.

The platform’s defining Fast-Light-Edge proposition, delivered through its breakthrough architecture, cut through the exhibition noise, generating immediate and widespread attention. MIMO earned exclusive features in top-tier media including Hong Kong Ta Kung Pao and China Securities Journal, while its product demonstration videos gained rapid traction across leading digital channels.

Addressing Foundational Challenges: Technical Dialogues That Matter

During the exhibitions, technical leaders from the United States, Spain, Singapore, Colombia, the UAE (Dubai), India, Pakistan, and Hong Kong SAR engaged in substantive dialogues with Ridger’s Asia team, raising questions that revealed systemic industry gaps:

Architectural Transformation & Strategic Positioning
“Can MIMO fundamentally replace legacy storage architectures—traditional NAS, unified, distributed, and parallel file systems—to deliver accelerated parallel training and high-concurrency inference?”
“With such exceptional performance, would deploying MIMO for traditional enterprise applications represent strategic overinvestment or forward-looking infrastructure?”

Mobile Deployment & Borderless Operations
“MIMO’s suitcase-sized footprint suggests unprecedented mobility. Can it truly accompany research teams globally like standard equipment? How does it maintain operational continuity across jurisdictions? What’s the customs protocol for such ‘technical luggage’?”

Seamless Integration & Global Accessibility
“In scenarios with unnetworked AI servers, can MIMO rapidly establish dedicated training environments with true plug-and-play functionality?”
“Does MIMO integrate transparently with existing AI infrastructure and software stacks without requiring modifications?”
“Beyond Asia-Pacific, what’s the procurement pathway for MIMO? Which currencies and payment methods are accommodated?”

Architectural Breakthrough: Redefining What’s Possible

Addressing these operational realities, Ridger demonstrated MIMO’s system-level value—transcending its role as a storage device to become an architectural cornerstone. MIMO serves as both a high-performance data hub for large-scale GPU clusters and a flexible edge deployment platform, extending seamlessly to desktop environments where it orchestrates workflows with various DGX Spark units based on NVIDIA’s GB10 Grace Blackwell superchip.

Notably, eight global OEM partners—including Dell, HPE, Lenovo, xFusion, H3C, MSI, GIGABYTE, and Acer—have concurrently launched Spark versions based on NVIDIA’s GB10 Grace Blackwell superchip, creating a robust compatibility foundation for MIMO’s ecosystem integration.

This architecture enables independent AI clusters supporting up to 16 computing nodes within constrained environments, managing the complete workflow from large-scale pre-training and fine-tuning to production inference—effectively democratizing enterprise-grade AI capabilities for labs, edge sites, and distributed teams.

As Zhu Ting, an industry observer from Beijing, noted: “This represents the ‘IBM PC moment’ for AI infrastructure—transforming specialized capability into accessible utility.”

Market Validation Through Early Adoption

Market response has been decisive. Following the exhibitions, pioneering organizations across pathological image foundation model development, legal-tech innovation, industrial visual inspection, and naked-eye 3D content production have joined Ridger’s Early Access program, validating the architecture’s transformative potential in real-world operational contexts.

Global Rollout: Accelerating Accessibility

Responding to accelerating global demand, Ridger confirmed the imminent launch of the complete MIMO portfolio and optimized solution bundles for specific DGX Spark configurations through the Ridger Official Global Store. Designed as a frictionless procurement channel, the platform will support diverse payment options including multiple fiat currencies and cryptocurrencies—streamlining access to advanced AI infrastructure.

Organizations seeking deeper understanding of MIMO and its integrated lightweight AI solution with DGX Spark are invited to connect with Ridger team or its strategic partner, NVIDIA Elite Solution Partner SinoInfo.
Hashtag: #Technology #ESG #AI #GPU #Enterprise #Finance #Storage #Flash #Compute #DGX-Spark #NVIDIA #AI-Lab #GDS #NAS #AI-Native



The issuer is solely responsible for the content of this announcement.

Ridger

Ridger is a global technology pioneer building next-generation computing & storage infrastructure for the AI era. Born in the East and operating worldwide, Ridger challenges conventional paths to create new technological paradigms.

The team unites seasoned experts from global storage leaders with visionary AI architects, all driven by a shared mission to democratize cutting-edge technology, rejects incremental improvements and hollow prestige, focusing exclusively on foundational breakthroughs that deliver tangible value and sustainable impact.

From architecture to implementation and from service to empowerment, Ridger provides end-to-end solutions that help clients worldwide ascend to their highest summits.

Continue Reading

Media OutReach

Johnson & Johnson and Asia Pacific Patient Advocacy Group Leaders Unite to Strengthen Shared Decision-Making in Lung Cancer Care

Published

on

Patient survey finds that those engaged in shared decision-making were 11 times more likely to report higher satisfaction with their treatments, with 90% of lung cancer patients in Japan wanting to play an active role in their treatment decisions[1]

J&J deepens its commitment to patient empowerment in Asia Pacific by launching J&J withMe, a new patient portal offering tailored patient resources, and co-driving market-specific initiatives with patient advocacy groups

SINGAPORE – Media OutReach Newswire – 11 December 2025 – Johnson & Johnson announced the next phase of The 3rd Opinion campaign across Asia Pacific, focused on championing shared decision-making between lung cancer patients and healthcare professionals through events and stakeholder engagements at ESMO Asia 2025 in Singapore.

At a Patient Reception on 6th December 2025, 20 leaders from 17 patient advocacy groups from across Asia Pacific, Europe and the United States shared their support for the need to strengthen shared decision-making. On December 7, 2025, the ESMO Asia 2025 Symposium, ‘Advancing EGFRm NSCLC Treatment Through Shared Decision-Making’ highlighted the role of healthcare professionals not only in making sense of the data but also in helping patients and their families navigate complex decision-making.

“High prevalence in Asia of certain NSCLC mutations makes the choice of first-line therapy absolutely critical. Treatment decisions must balance clinical objectives with patient values — weighing disease biology, survival prospects, durable disease control and the tradeoffs of side effects. That’s why shared decision-making is essential: clinicians should present all appropriate treatment options, so the final choice is collaborative and aligned with each patient’s goals,” said Professor Zhu Zhengfei, Director of the Radiation Oncology Department, Fudan University Shanghai Cancer Center.

“When lung cancer patients are empowered to speak up and understand their options, they are more likely to continue the treatment and their dignity is preserved. Initiatives like ‘The 3rd Opinion’ are vital for fostering truly patient-centered partnerships between people living with cancer and their healthcare teams,” noted Ms. Liu Yiting, Marketing & Branding Director, China MeetHealth Mi-Jian Patient Community.

“The shared commitment validates what many people living with lung cancer have long expressed: shared decision making is essential. From our experience supporting patients, meaningful conversations with clinicians help acknowledge patients’ experiences, address their concerns, and preserving their hopes,” added Mr. Jung-Il Cho, Chairman of Korea Lung Cancer Patients Association.

Our commitment comes off the back of a recent patient survey revealing that 90% of Japanese lung cancer patients want to play an active role in their treatment decisions. The survey also found that shared decision-making, where physicians and patients jointly compare treatment options and decide together, is the strongest driver of treatment satisfaction.1

Patient survey finds that those engaged in shared decision-making were 11 times more likely to report higher satisfaction with their treatments, with 90% of lung cancer patients in Japan wanting to play an active role in their treatment decisions. This finding underscores the importance of shared decision-making and patient-centered care.1

To bridge the gap between patients’ desire to engage in shared decision making and their lack of practical support, J&J has launched “J&J withMe”, an online hub that equips lung cancer patients and caregivers with tailored toolkits and conversation guides to prepare for consultations and make informed, personalized treatment decisions.

Anthony Elgamal, Vice President of Oncology, Johnson & Johnson Innovative Medicine Asia Pacific said, The 3rd Opinion truly puts patients at the center of care. As part of our deep commitment to address patients’ unmet needs, we will continue partnering with patient advocacy groups and healthcare professionals to help patients to find their voice and the moment when medical advice meets what truly matters to patients.”

图像 (3)

In recognition of diverse cultural and clinical norms across Asia Pacific, J&J has also rolled out tailored market activations in collaboration with local patient advocacy groups:

  • Provision of patient resources such as the “Lung Cancer Book of Answers” in China, ‘Value of Time’ video for patients in Japan, and educational assets in India and Australia/New Zealand;
  • Digital and social media engagement featuring patients and creators discussing the importance of shared decision-making across Singapore, Malaysia, Philippines, Thailand, and Vietnam;
  • Event engagement via the establishment of a patient advisory board in India;
  • Corporate Social Responsibility program with a lung cancer patient group in Korea, bringing employees and patients together to better understand the disease burden of patients and strengthen emotional support for the patient community.

###

About the 3rd Opinion

“The 3rd Opinion”, the patient’s own opinion, is a new term that sparks a social movement in the lung cancer treatment journey – designed to elevate the patient voice and empower individuals to take an active role in shaping their treatment plan. By prioritizing shared decision-making between patients and healthcare professionals, this collaborative approach ensures that treatment choices are aligned to each patient’s goals, preferences and circumstances. This results in more informed decisions, greater patient satisfaction, and the best possible outcomes.

About Non-Small Cell Lung Cancer

Worldwide, lung cancer is one of the most common cancers, with NSCLC making up 80 to 85 percent of all lung cancer cases.[1], [2] The main subtypes of NSCLC are adenocarcinoma, squamous cell carcinoma, and large cell carcinoma.[3] Among the most common driver mutations in NSCLC are alterations in EGFR, which is a receptor tyrosine kinase controlling cell growth and division.[4] EGFR mutations are present in 10 to 15 percent of Western patients with NSCLC with adenocarcinoma histology and occur in 40 to 50 percent of Asian patients.[5], [6],[7],[8],[9],[10] EGFR ex19del or EGFR L858R mutations are the most common EGFR mutations.[11] The five-year survival rate for all people with advanced NSCLC and EGFR mutations treated with EGFR tyrosine kinase inhibitors (TKIs) is less than 20 percent.[12],[13] EGFR exon 20 insertion mutations are the third most prevalent activating EGFR mutation.[14] Patients with EGFR exon 20 insertion mutations have a real-world five-year overall survival (OS) of eight percent in the frontline setting, which is worse than patients with EGFR ex19del or L858R mutations, who have a real-world five-year OS of 19 percent.[15]By comparison, other common cancers, such as breast and prostate cancer have a 5-year real world OS of 90% and 97% respectively[16].


[1] Johnson & Johnson lung cancer patient quantitative survey conducted in Japan, 2025

[2] The World Health Organization. Cancer. https://www.who.int/news-room/fact-sheets/detail/cancer. Accessed March 2025.

[3] American Cancer Society. What is Lung Cancer? https://www.cancer.org/content/cancer/en/cancer/lung-cancer/about/what-is.html. Accessed March 2025.

[4] Oxnard JR, et al. Natural history and molecular characteristics of lung cancers harboring EGFR exon 20 insertions. J Thorac Oncol. 2013 Feb;8(2):179-84. doi: 10.1097/JTO.0b013e3182779d18.

[5] Bauml JM, et al. Underdiagnosis of EGFR Exon 20 Insertion Mutation Variants: Estimates from NGS-based Real World Datasets. Abstract presented at: World Conference on Lung Cancer Annual Meeting; January 29, 2021; Singapore.

[6] The World Health Organization. Cancer. https://www.who.int/news-room/fact-sheets/detail/cancer. Accessed March 2025.

[7] American Cancer Society. What is Lung Cancer? https://www.cancer.org/content/cancer/en/cancer/lung-cancer/about/what-is.html. Accessed March 2025.

[8] Pennell NA, et al. A phase II trial of adjuvant erlotinib in patients with resected epidermal growth factor receptor-mutant non-small cell lung cancer. J Clin Oncol. 37:97-104.

[9] Burnett H, et al. Epidemiological and clinical burden of EGFR exon 20 insertion in advanced non-small cell lung cancer: a systematic literature review. Abstract presented at: World Conference on Lung Cancer Annual Meeting; January 29, 2021; Singapore.

[10] Zhang YL, et al. The prevalence of EGFR mutation in patients with non-small cell lung cancer: a systematic review and meta-analysis. Oncotarget. 2016;7(48):78985-78993.

[11] Midha A, et al. EGFR mutation incidence in non-small-cell lung cancer of adenocarcinoma histology: a systematic review and global map by ethnicity. Am J Cancer Res. 2015;5(9):2892-2911.

[12] American Lung Association. EGFR and Lung Cancer. https://www.lung.org/lung-health-diseases/lung-disease-lookup/lung-cancer/symptoms-diagnosis/biomarker-testing/egfr. Accessed March 2025.

[13] Howlader N, et al. SEER Cancer Statistics Review, 1975-2016, National Cancer Institute. Bethesda, MD, https://seer.cancer.gov/csr/1975_2016/, based on November 2018 SEER data submission, posted to the SEER web site.

[14] Lin JJ, et al. Five-Year Survival in EGFR-Mutant Metastatic Lung Adenocarcinoma Treated with EGFR-TKIs. J Thorac Oncol. 2016 Apr;11(4):556-65

[15] Arcila, M. et al. EGFR exon 20 insertion mutations in lung adenocarcinomas: prevalence, molecular heterogeneity, and clinicopathologic characteristics. Mol Cancer Ther. 2013 Feb; 12(2):220-9.

[16] Girard N, et al. Comparative clinical outcomes for patients with NSCLC harboring EGFR exon 20 insertion mutations and common EGFR mutations. Abstract presented at: World Conference on Lung Cancer Annual Meeting; January 29, 2021; Singapore.

[17] Surveillance, Epidemiology, and End Results (SEER) Program, National Cancer Institute, 2024.

Hashtag: #Johnson&Johnson

The issuer is solely responsible for the content of this announcement.

About Johnson & Johnson

At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity.

Learn more at or at . Follow us at .

Johnson & Johnson Innovative Medicine Asia Pacific, a division of Johnson & Johnson International (Singapore) Pte. Ltd is a Johnson & Johnson company.

© Johnson & Johnson International (Singapore) Pte. Ltd. [2025] All rights reserved.

Continue Reading

Media OutReach

Skychakra Global Capital Strategy Upgrade: Advancing Cross-Border Listings and RWA Ecosystem

Published

on

HONG KONG SAR – Media OutReach Newswire – 11 December 2025 – Skychakra Group recently held a grand inauguration ceremony at the Hong Kong International Center, announcing the official acceleration of its globalization strategy. With a mission to “enhance individual energy, empower enterprise growth, and promote asset capitalization,” Skychakra simultaneously launched three major international initiatives: a cross-border listing incubation system, an RWA (Real World Assets) technology ecosystem, and the international upgrade of mind-body energy science, building a new economic ecosystem that spans technology, industry, and capital.

As a global hub for innovation and capital, Hong Kong serves as a significant gateway for the activation of Skychakra’s global strategy. This inauguration not only symbolizes the completion of the facility but also marks the comprehensive rollout of Skychakra’s international layout.

Official Launch of Cross-Border Listing Incubation Center

During the inauguration, Skychakra announced the establishment of a cross-border listing incubation center, led by a professional team qualified with SEC, PCAOB, and FINRA credentials, boasting over a hundred projects in cross-border listings. The service scope includes U.S. stocks, Hong Kong stocks, and SPACs. Unlike traditional investment banks and financial advisors, Skychakra offers a “full-link” service for enterprise capitalization, encompassing red-chip structure setup, financial and audit compliance, SEC and Hong Kong Stock Exchange filing guidance, dual-path IPO/SPAC design, market value management, enterprise internationalization guidance, and digital upgrades.

Originally planning to sign contracts for four companies at the conference, Skychakra exceeded expectations by signing 12, demonstrating its strong appeal and industry influence in cross-border listings and capital operations.

RWA Technology Ecosystem: Making Enterprise Assets Visible to the Financial System

Real World Assets (RWA) are becoming the core of global financial transformation. From BlackRock’s launch of tokenized funds to Hong Kong and Singapore incorporating RWA into financial infrastructure, RWAs are transitioning from concept to large-scale implementation. Skychakra emphasizes that small and medium-sized enterprises face common challenges such as lack of recognition for their assets within the financial system, difficulties in cross-border financing, and a lack of transparency in asset value.

The Skychakra RWA ecosystem will provide enterprises with: tokenizable asset identification, asset structuring and entitlement, on-chain mapping and minting, cross-border compliance design, global issuance and liquidity channels, and on-chain risk control and transparent tracking. The core value of RWA lies in reducing friction for enterprises in connecting to global capital, enhancing asset liquidity and valuation potential.

A Holistic Growth Model: “From People to Enterprises, From Enterprises to Capital”

Skychakra’s differentiated advantage stems from its foundational logic of “starting with people.” The Skychakra energy courses utilize scientific equipment to measure energy fields, emotional frequencies, and meridian states, assisting individuals in enhancing stability, insight, and decision-making abilities.

Based on this foundation, Skychakra constructs three major systems:

1. Enterprise Growth System: Enhancing organizational capabilities, introducing international business, and providing capital operation guidance.

2. Capitalization System: Building global financing capabilities through listings and RWA structures.

3. Asset Digitalization System: Making enterprise value quantifiable, verifiable, and tradable.

These three systems dynamically interact in a spiral structure, forming Skychakra’s unique full-link growth ecosystem.

Conclusion: Global Layout for Greater International Influence

The inauguration of Skychakra’s Hong Kong International Center signifies the official implementation of the group’s globalization strategy. Looking forward, the focus will be on Hong Kong as the core, with Asia as the main axis, while establishing deep collaborations with the North American and Middle Eastern markets. Through this global layout, Skychakra is creating a new organizational model that transcends regions, industries, and capital, enabling enterprises to achieve value flow in the global market and allowing more Asian companies to gain a stronger voice on the international stage.

Hashtag: #Skychakra

The issuer is solely responsible for the content of this announcement.

Continue Reading

Trending